Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$13,043,758
+$1,365,634 QoQ
Shares Held
51,835
-3.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#791
of 4,150 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wilmington Savings Fund Society, FSB holds $202,731,943 across 16 Drug Manufacturers - General names. ABBV ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
348,943 | $88,621,053 | |
| 2 | LLY |
ELI LILLY & Co
|
27,892 | $33,454,503 | |
| 3 | MRK |
Merck & Co., Inc.
|
223,656 | $28,739,795 | |
| 4 | AMGN |
Amgen Inc
|
47,244 | $17,107,996 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
51,835 | $13,043,758 | |
| 6 | AZN |
Astrazeneca PLC
|
32,878 | $6,234,325 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
106,605 | $6,142,579 | |
| 8 | PFE |
Pfizer Inc
|
185,530 | $4,467,561 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,043,758 | 51,835 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $11,678,124 | 53,695 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $11,918,037 | 52,160 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $11,975,248 | 51,720 | Shares | Defined | 2025-11-20 | |
| 2025-06-30 | $14,441,235 | 77,800 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $17,429,339 | 83,187 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $15,849,062 | 89,190 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $16,237,397 | 82,223 | Shares | Defined | 2024-11-25 | |
| 2024-06-30 | $5,487,267 | 31,992 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $6,020,043 | 33,059 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $5,214,565 | 34,983 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $4,793,019 | 35,575 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,551,494 | 34,834 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,712,590 | 35,348 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,907,521 | 36,566 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,518,814 | 36,033 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,156,612 | 37,978 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,172,143 | 38,199 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,246,840 | 39,370 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $4,485,436 | 39,821 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $4,134,977 | 38,209 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $4,203,279 | 39,228 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,540,299 | 40,419 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,095,970 | 41,719 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,232,968 | 42,433 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||